Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Smith

Showing results (91-100 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|February 22, 2011
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programPeter J Houghton, Richard Gorlick, E Anders Kolb, et al.
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|January 11, 2013
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing ProgramRichard B Lock, Hernan Carol, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
JCO Clinical Cancer Informatics|April 8, 2026
Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated AnalysisSubhashini Jagu, Jaime M Guidry Auvil, Mark D Cunningham, et al.
Pageof 19

Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|February 22, 2011
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programPeter J Houghton, Richard Gorlick, E Anders Kolb, et al.
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|January 11, 2013
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing ProgramRichard B Lock, Hernan Carol, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
JCO Clinical Cancer Informatics|April 8, 2026
Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated AnalysisSubhashini Jagu, Jaime M Guidry Auvil, Mark D Cunningham, et al.
Pageof 19